Live Breaking News & Updates on Dermatology Research Associates|Page 1

Stay updated with breaking news from Dermatology research associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tapinarof Cream Safe, Effective for Plaque Psoriasis in Intertriginous Areas

Two-thirds of participants achieved complete disease clearance at week 12, with a median time to complete disease clearance of 8 weeks. ....

Los Angeles , United States , Las Vegas , Howard Sofen , Dermatology Research Associates In Los Angeles , Healthday News , Fall Clinical Dermatology Conference , Dermatology Research Associates , Physician Global Assessment , Peak Pruritus Numeric Rating Scale ,

Tapinarof cream safe, effective for plaque psoriasis in intertriginous areas

Tapinarof cream safe, effective for plaque psoriasis in intertriginous areas
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Los Angeles , United States , Las Vegas , Howard Sofen , Dermatology Research Associates In Los Angeles , Fall Clinical Dermatology Conference , Dermatology Research Associates , Physician Global Assessment , Peak Pruritus Numeric Rating Scale ,

Dermavant Sciences: Dermavant Presents Positive Results from Phase 4 Open-Label Trial of VTAMA (tapinarof) Cream, 1% for the Treatment of Intertriginous Plaque Psoriasis in Adults at 43rd Annual Fall Clinical Dermatology Conference

Dermavant Sciences: Dermavant Presents Positive Results from Phase 4 Open-Label Trial of VTAMA (tapinarof) Cream, 1% for the Treatment of Intertriginous Plaque Psoriasis in Adults at 43rd Annual Fall Clinical Dermatology Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Howard Sofen , Las Vegas , Todd Zavodnick , Laurence Watts , Indiens Wirtschaft , Angela Salerno Robin , Ihre Chancen , Philipm Brown , Board Of The National Psoriasis Foundation , Dermavant Sciences Gmb , National Psoriasis , Dermatology Research Associates , Dermavant Sciences Inc , Roivant Sciences , Linkedin Dermavant Sciences , Dermavant Sciences , Iqvia National Prescription Audit , Physician Global Assessment , Peak Pruritis Numeric Rating Scale , Dermatology Life Quality Index , Annual Fall Clinical Dermatology Conference , Chief Executive Officer , Chief Medical Officer , Local Tolerability Scale , Peak Pruritus Numeric Rating Scale ,

Significant Improvement in Hand Eczema With Pan-JAK Inhibitor

email article
More than half of patients with steroid-refractory hand eczema responded quickly to a pan-Janus kinase (JAK) inhibitor in a randomized, placebo-controlled trial.
After 16 weeks of treatment, patients treated with the higher of two doses of gusacitinib had a 69.5% reduction in target lesion symptom score (TLSS), as compared with 49% among patients randomized to the lower dose of the drug, and 33.5% of placebo-treated patients. Response to gusacitinib occurred as early as 2 weeks after the start of treatment.
The higher dose of the JAK inhibitor led to a 72% improvement in the Hand Eczema Severity Index (HECSI) at 16 weeks, as compared with 20.8% in the placebo arm, reported Howard Sofen, MD, of Dermatology Research Associates and the University of California Los Angeles, at the American Academy of Dermatology virtual meeting. ....

United States , Howard Sofen , Charles Bankhead , University Of California Los Angeles , Dermatology Research Associates , American Academy Of Dermatology , Hand Eczema Severity Index , California Los Angeles , American Academy , Physician Global Assessment , Medpage Today , ஒன்றுபட்டது மாநிலங்களில் , சார்லஸ் வங்கித் தலை , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா லாஸ் ஏஞ்சல்ஸ் , தோல் நோய் ஆராய்ச்சி கூட்டாளிகள் , அமெரிக்கன் கலைக்கழகம் ஆஃப் தோல் நோய் , கலிஃபோர்னியா லாஸ் ஏஞ்சல்ஸ் , அமெரிக்கன் கலைக்கழகம் , மருத்துவர் உலகளாவிய மதிப்பீடு ,